* Azenta Inc AZTA.OQ reported quarterly adjusted earnings
of 2
cents per share for the quarter ended in December, lower than
the same quarter last year, when the company reported EPS of 12
cents. The mean expectation of six analysts for the quarter was
for a loss of 3 cents per share. Wall Street expected results to
range from -5 cents to -1 cents per share.
* Revenue fell 13.5% to $154.32 million from a year ago;
analysts
expected $151.00 million.
* Azenta Inc's reported EPS for the quarter was a loss of 28
cents.
* The company reported a quarterly loss of $15.72 million.
* Azenta Inc shares had risen by 2.4% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 141.7% in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"
Wall Street's median 12-month price target for Azenta Inc is
$73.00
This summary was machine generated from LSEG data February 7 at
10:53 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.03 0.02 Beat
Sep. 30 2023 0.02 0.13 Beat
Jun. 30 2023 -0.02 0.13 Beat
Mar. 31 2023 -0.02 -0.06 Missed